Sei Investments CO Krystal Biotech, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Sei Investments CO holds 34,249 shares of KRYS stock, worth $5.65 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

34,249

Previous 40,115 14.62%

Holding current value

$5.65 Million

Previous $7.37 Million 15.45%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$174.7 - $213.66 $1.02 Million - $1.25 Million	-5,866 Reduced 14.62%	34,249 $6.23 Million
Q2 2024 Aug 13, 2024	BUY	$153.12 - $183.64 $974,302 - $1.17 Million	6,363 Added 18.85%	40,115 $7.37 Million
Q1 2024 May 07, 2024	BUY	$108.01 - $179.35 $2.05 Million - $3.4 Million	18,968 Added 128.3%	33,752 $6.01 Million
Q4 2023 Feb 14, 2024	SELL	$96.0 - $128.29 $1.93 Million - $2.58 Million	-20,117 Reduced 57.64%	14,784 $1.83 Million
Q3 2023 Nov 14, 2023	BUY	$108.51 - $130.22 $2.35 Million - $2.82 Million	21,670 Added 163.78%	34,901 $4.05 Million
Q2 2023 Aug 11, 2023	BUY	$78.48 - $130.32 $21,895 - $36,359	279 Added 2.15%	13,231 $1.55 Million
Q1 2023 May 12, 2023	SELL	$72.39 - $84.27 $257,563 - $299,832	-3,558 Reduced 21.55%	12,952 $1.04 Million
Q4 2022 Feb 10, 2023	SELL	$63.14 - $79.9 $23,993 - $30,362	-380 Reduced 2.25%	16,510 $1.31 Million
Q3 2022 Nov 14, 2022	SELL	$64.85 - $82.4 $12,969 - $16,480	-200 Reduced 1.17%	16,890 $1.18 Million
Q2 2022 Aug 15, 2022	SELL	$48.93 - $73.47 $113,664 - $170,670	-2,323 Reduced 11.97%	17,090 $1.12 Million
Q1 2022 May 13, 2022	BUY	$51.99 - $72.11 $155,866 - $216,185	2,998 Added 18.26%	19,413 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$39.81 - $88.24 $375,686 - $832,720	9,437 Added 135.24%	16,415 $1.15 Million
Q3 2021 Nov 12, 2021	SELL	$52.01 - $71.77 $6,917 - $9,545	-133 Reduced 1.87%	6,978 $364,000
Q2 2021 Aug 06, 2021	SELL	$62.14 - $81.82 $8,637 - $11,372	-139 Reduced 1.92%	7,111 $484,000
Q1 2021 May 12, 2021	SELL	$59.42 - $85.46 $15,211 - $21,877	-256 Reduced 3.41%	7,250 $559,000
Q2 2020 Aug 17, 2020	BUY	$37.03 - $60.0 $277,947 - $450,360	7,506 New	7,506 $311,000
Q2 2020 Aug 11, 2020	SELL	$37.03 - $60.0 $355,117 - $575,400	-9,590 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$35.02 - $65.64 $32,848 - $61,570	938 Added 10.84%	9,590 $415,000
Q4 2019 Feb 06, 2020	SELL	$33.17 - $65.23 $71,249 - $140,114	-2,148 Reduced 19.89%	8,652 $479,000
Q3 2019 Nov 12, 2019	SELL	$34.72 - $51.3 $45,170 - $66,741	-1,301 Reduced 10.75%	10,800 $375,000
Q2 2019 Aug 14, 2019	BUY	$27.2 - $41.2 $329,147 - $498,561	12,101 New	12,101 $487,000

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.3M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.23B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Krystal Biotech, Inc. Transaction History